These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37079533)

  • 1. Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations.
    Baassi M; Moussaoui M; Soufi H; Rajkhowa S; Sharma A; Sinha S; Belaaouad S
    PLoS One; 2023; 18(4):e0284539. PubMed ID: 37079533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics and ligand docking of a hinge region variant of South African HIV-1 subtype C protease.
    Zondagh J; Balakrishnan V; Achilonu I; Dirr HW; Sayed Y
    J Mol Graph Model; 2018 Jun; 82():1-11. PubMed ID: 29625416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning-guided design of potent darunavir analogs targeting HIV-1 proteases: A computational approach for antiretroviral drug discovery.
    Chuntakaruk H; Boonpalit K; Kinchagawat J; Nakarin F; Khotavivattana T; Aonbangkhen C; Shigeta Y; Hengphasatporn K; Nutanong S; Rungrotmongkol T; Hannongbua S
    J Comput Chem; 2024 May; 45(13):953-968. PubMed ID: 38174739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
    Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
    BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Molecular Dynamics Simulations and Energy Analysis Unravel the Dynamic Properties and Binding Mechanism of Mutants HIV-1 Protease with DRV and CA-p2.
    Wang R; Zheng Q
    Microbiol Spectr; 2022 Apr; 10(2):e0074821. PubMed ID: 35319278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV-1 protease variants.
    Nayak C; Chandra I; Singh SK
    J Cell Biochem; 2019 Jun; 120(6):9063-9081. PubMed ID: 30506751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.
    Karnati KR; Wang Y
    J Mol Graph Model; 2019 Nov; 92():112-122. PubMed ID: 31351319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FMO-guided design of darunavir analogs as HIV-1 protease inhibitors.
    Chuntakaruk H; Hengphasatporn K; Shigeta Y; Aonbangkhen C; Lee VS; Khotavivattana T; Rungrotmongkol T; Hannongbua S
    Sci Rep; 2024 Feb; 14(1):3639. PubMed ID: 38351065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study.
    Zhou H; Zhu M; Ma L; Zhou J; Dong B; Zhang G; Cen S; Wang Y; Wang J
    PLoS One; 2020; 15(7):e0235483. PubMed ID: 32697773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques.
    Okafor SN; Angsantikul P; Ahmed H
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
    Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
    Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdependence of Inhibitor Recognition in HIV-1 Protease.
    Paulsen JL; Leidner F; Ragland DA; Kurt Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2017 May; 13(5):2300-2309. PubMed ID: 28358514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
    Arodola OA; Soliman ME
    Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir.
    Aoki M; Hayashi H; Yedidi RS; Martyr CD; Takamatsu Y; Aoki-Ogata H; Nakamura T; Nakata H; Das D; Yamagata Y; Ghosh AK; Mitsuya H
    J Virol; 2015 Nov; 90(5):2180-94. PubMed ID: 26581995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of conceptual DFT descriptors and docking scores on the QSAR models of HIV protease inhibitors.
    Srivastava HK; Choudhury C; Sastry GN
    Med Chem; 2012 Sep; 8(5):811-25. PubMed ID: 22741804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
    Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
    Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.
    Meher BR; Wang Y
    J Mol Graph Model; 2015 Mar; 56():60-73. PubMed ID: 25562662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic and structural analysis of HIV protease resistance to darunavir - analysis of heavily mutated patient-derived HIV-1 proteases.
    Kožíšek M; Lepšík M; Grantz Šašková K; Brynda J; Konvalinka J; Rezáčová P
    FEBS J; 2014 Apr; 281(7):1834-47. PubMed ID: 24785545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis.
    Mata-Munguía C; Escoto-Delgadillo M; Torres-Mendoza B; Flores-Soto M; Vázquez-Torres M; Gálvez-Gastelum F; Viniegra-Osorio A; Castillero-Manzano M; Vázquez-Valls E
    BMC Bioinformatics; 2014 Mar; 15():72. PubMed ID: 24629078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.